How Does Zepbound Work in the Body?

Zepbound is an injectable form of tirzepatide that works by activating both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual action signals your brain that you feel full sooner, keeps food in your stomach longer, and helps your body use blood sugar more smoothly, so you naturally eat less and burn stored fat. Adults with obesity or overweight plus a weight-related condition who pair Zepbound with reduced-calorie meals and more activity can lose an average of 15 to 20 percent of their starting weight over 1 year, according to the SURMOUNT trials (fda.gov). Zepbound must be prescribed, started at a low dose, and increased only under a healthcare provider’s guidance.

• Zepbound is the only FDA-approved weight-loss shot that targets both GIP and GLP-1 receptors at the same time.
• In clinical studies, participants taking the highest 15 mg dose lost up to 22.5 percent of their body weight after 72 weeks with lifestyle support.
• The medication slows stomach emptying for about 4 hours after a meal, which reduces hunger and “food noise.”
• People with a body-mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition, are eligible for treatment.
• Nausea, constipation, and fatigue are the most common side effects and usually improve after the first 8 weeks on treatment.

What Zepbound Is and Why It Was Approved

Zepbound is the brand-name, once-weekly injection of the active ingredient tirzepatide, approved by the U.S. Food and Drug Administration in November 2023 for chronic weight management. The same molecule was first cleared in 2022 under the brand Mounjaro to treat type 2 diabetes. Like other GLP-1 medicines such as Ozempic and Wegovy, Zepbound is intended to be used long term alongside a calorie-reduced diet and increased physical activity.

Definition: Zepbound is a dual GIP/GLP-1 receptor agonist that lowers appetite, improves insulin sensitivity, and supports sustained weight loss in adults with obesity or overweight plus a related medical problem.

How Zepbound Works Inside the Body

Zepbound copies the effects of two natural incretin hormones, GIP and GLP-1, which are released from your small intestine after you eat. Tirzepatide binds to both receptors and triggers a cascade of signals that affect multiple organs.

In the brain: appetite control

Activation of GLP-1 receptors in the hypothalamus dampens hunger signals, while GIP receptor activity appears to amplify this satiety message. The result is fewer cravings and an earlier sense of fullness during meals.

In the stomach: slower emptying

Zepbound keeps food in the stomach longer, so glucose from carbohydrates enters the bloodstream more gradually. This steadier blood-sugar curve reduces the post-meal energy crash that can drive snacking.

In the pancreas and liver: better glucose handling

The dual-acting drug boosts insulin release when blood sugar rises and suppresses the liver’s glucose output between meals, a key reason tirzepatide also improves A1C in people with type 2 diabetes.

How Much Weight Can You Lose on Zepbound?

Across the SURMOUNT-3 and SURMOUNT-4 trials submitted to the FDA, adults taking Zepbound 10 mg to 15 mg lost 18 to 21 percent of their starting weight after 72 to 88 weeks, versus 3 percent with placebo. Weight loss increased with the dose and plateaued after about 12 to 15 months.

Most of the loss comes from body fat rather than lean tissue, according to imaging sub-studies referenced in the prescribing information (fda.gov).

Who Benefits Most

Zepbound is intended for adults aged 18 and older with a BMI of at least 30, or 27 with weight-related problems such as high blood pressure, obstructive sleep apnea, or type 2 diabetes. People who have tried lifestyle changes alone without lasting success, and who are ready for a long-term medication plan, tend to see the greatest benefit.

Not a fit if you have:

• Personal or family history of medullary thyroid cancer
• Multiple endocrine neoplasia syndrome type 2
• Severe gastrointestinal disease such as gastroparesis
• A known hypersensitivity to tirzepatide or any ingredient in the formulation

Side Effects and Management Tips

Most side effects stem from Zepbound’s action on the gut and usually fade as your body adjusts. Starting at 2.5 mg and increasing no faster than every 4 weeks helps.

Nausea or vomiting: Eat smaller, low-fat meals, sip ginger tea, and avoid lying down right after eating.
Constipation: Drink at least 2 liters of water daily, add fiber-rich foods, and consider a gentle stool softener if approved by your provider.
Fatigue: Ensure you consume enough protein and complex carbs, and review any calorie targets with a dietitian.
Injection-site irritation: Rotate between the abdomen, thigh, and upper arm, and let the solution warm to room temperature before injecting.

Alternatives if You Cannot Get Zepbound

If Zepbound is out of stock, not covered by insurance, or you do not meet the FDA criteria, other evidence-based options exist. Your provider can help you weigh the pros and cons.

Other FDA-approved GLP-1 drugs: Wegovy (semaglutide 2.4 mg weekly) has similar weight-loss efficacy but targets only the GLP-1 receptor.
Compounded GLP-1 therapy: compounded tirzepatide and compounded semaglutide are not FDA-approved but may be considered when commercial products are inaccessible, under a licensed prescriber’s judgment.
Oral medications: Older anti-obesity pills such as phentermine-topiramate and bupropion-naltrexone work through appetite suppression in the brain but offer lower average weight loss.
Metabolic surgery: Bariatric procedures typically produce the greatest and most durable results but require lifelong follow-up and carry surgical risks.

For a deeper dive into timelines, see our guide How long does tirzepatide take to work?